http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2584414-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-47 |
| filingDate | 2012-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d9f0727a33c5e2966358417fcf75d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77af737809ae82c9fc44051fe09f845e |
| publicationDate | 2016-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2584414-T3 |
| titleOfInvention | Use of MAD2L2 as a stratification marker in the treatment of breast tumors with new pan-CDK inhibitors |
| abstract | Use of MAD2L2 as a stratification marker in the treatment of breast tumors with a compound of general formula (I) in which ** Formula ** X represents -O- or NH- and R1 represents a methyl, ethyl, propyl or Isopropyl and R2 and R3 represent, independently of each other, hydrogen, a methyl or ethyl group and R4 represents a C1-C6 alkyl group or a C3-C7 cycloalkyl ring, or with one of its physiologically compatible salts, diastereomers or enantiomers. |
| priorityDate | 2011-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 497.